Found 6 matching trials
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
PHASE2This phase 2 multicenter, open-label clinical trial will evaluate safety an...
Location
Cedars-Sinai Medical Center
Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
PHASE2This is a phase II, dose ranging, multicenter, randomized, double-blind, pl...
Location
CHU de Nice - Hôpital Pasteur
A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors
PHASE1A study of sequential administration of oral sapacitabine and oral Selicicl...
Location
Dana Farber Cancer Institute
Treatment of Cushing's Disease With R-roscovitine
PHASE2The investigators hypothesize that R-roscovitine will suppress pituitary co...
Location
Cedars-Sinai Medical Center
Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer
PHASE2A phase 2 study to evaluate efficacy of oral seliciclib in treating non-sma...
Location
Arizona Cancer Center
Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC)
PHASE1The goal of this clinical research study is to find the highest tolerable d...
Location
Multiple Locations